Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Diabetes Technol Ther ; 11(2): 107-11, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19848577

RESUMO

BACKGROUND: Pancreatic neuronal changes associated with beta cell loss in type 1 diabetes mellitus are complex, involving, in part, parasympathetic mechanisms to compensate for preclinical hyperglycemia. The parasympathetic neurotransmitter acetylcholine (ACh) mediates insulin release via M3 muscarinic receptors on islet beta cells. The vesicular ACh transporter (VAChT) receptor has been shown to be a useful marker of cholinergic activity in vivo. The positron emission tomography (PET) radiotracer (+)-4-[(18)F]fluorobenzyltrozamicol ([(18)F]FBT) binds to the VAChT receptor on presynaptic cholinergic neurons and can be quantified by PET. The compound 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), available in a tritiated form, binds to M3 muscarinic receptors on beta cells and is a potential target for assessing pancreatic beta cell mass. In this study, we investigate the feasibility of dual radiotracer analysis in identifying neurofunctional changes that may signify type 1 diabetes mellitus in its early preclinical state. METHODS: Ex vivo determinations of pancreatic uptake were performed in prediabetic nonobese diabetic mice and controls after intravenous injection of [(18)F]FBT or 4-[(3)H]DAMP. Beta cell loss in prediabetic mice was confirmed using immunohistochemical methods. RESULTS: [(18)F]FBT uptake was significantly higher in prediabetic pancreata than controls: 3.22 +/- 0.81 and 2.51 +/- 1.04, respectively (P < 0.03). 4-[(3)H]DAMP uptake was significantly lower in prediabetic pancreata than controls: 0.612 +/- 0.161 and 0.968 +/- 0.364, respectively (P = 0.01). CONCLUSIONS: These data suggest that a combination of radiotracer imaging agents that bind to neuronal elements intimately involved in insulin production may be an effective method of evaluating changes associated with early beta cell loss using PET.


Assuntos
Radioisótopos de Flúor , Células Secretoras de Insulina/patologia , Pâncreas/patologia , Estado Pré-Diabético/diagnóstico , Trítio , Animais , Fluorbenzenos/farmacocinética , Células Secretoras de Insulina/diagnóstico por imagem , Camundongos , Pâncreas/diagnóstico por imagem , Parassimpatolíticos/farmacocinética , Piperidinas/farmacocinética , Estado Pré-Diabético/diagnóstico por imagem , Estado Pré-Diabético/patologia , Radiografia
2.
J Comput Assist Tomogr ; 28(1): 98-100, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14716240

RESUMO

Glutaric aciduria type I is a rare disorder of organic acid metabolism caused by deficiency of glutaryl-CoA dehydrogenase. We report the cranial computed tomography (CT) and magnetic resonance (MR) imaging findings in a 5-month-old girl with this disorder who presented with an acute dystonic syndrome. CT findings demonstrated only subtle loss of attenuation in the basal ganglia, MR spectroscopy was normal, and conventional MR images showed increased T2-signal limited to the putamina. Diffusion-weighted MR imaging demonstrated more extensive disease than was apparent either on CT or on the conventional MR images, including bilateral involvement of the putamina, globus pallidus, and caudate nuclei, consistent with acute necrosis of the corpus striatum and lentiform nuclei.


Assuntos
Encefalopatias Metabólicas Congênitas/diagnóstico , Corpo Estriado/patologia , Imagem de Difusão por Ressonância Magnética , Glutaratos/urina , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/deficiência , Doença Aguda , Feminino , Glutaril-CoA Desidrogenase , Humanos , Lactente , Necrose , Putamen/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA